Impact of austerity on European pharmaceutical policy and pricing
Deloitte U.K. Centre for Health Solutions report addresses current challenges faced by the pharmaceutical industry due to on-going austerity in Europe.
Shaping the evolution of the industry
The Life Sciences practice at Deloitte helps our clients meet the challenges and face the opportunities that are shaping today’s industry. Our understanding of these challenges and the ability to quickly respond with integrated, comprehensive solutions puts us in a unique position to help.
Pharmaceuticals companies are experiencing a period of unprecedented change. Driven by shifts in age and demographics, disease, the entry of new technologies, increased government regulations, and the pace of health care inflation, pharmaceuticals companies will have to dramatically change in order to cope with the future industry environment. The Life Sciences European practice along with Deloitte member firms worldwide can help you address these and other challenges in today's complex life sciences environment.
Deloitte European Life Sciences Centre of Excellence
Life Sciences Centre of Excellence Deloitte Switzerland.
Increased reliance on analytics is driving decision-making, behavioural change and collaboration in unprecedented ways.
Global employer services
Among the most serious challenges businesses face today is compliance with multifaceted tax laws and labor regulations. Deloitte offers well-rounded plans and program development strategies that can help transform global employment programs in a tax- and cost-efficient manner.